The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Democratic socialist headed for $142K legislature salary begs for rent handout, deletes post after backlash
Multiple people killed in shooting at Idaho In-N-Out restaurant, suspect dead
ICE arrests illegal immigrant accused of rape, multiple sex crimes after release from Maryland jail
Father of 10-year-old boy breaks silence after viral beach rescue: ‘No way I could ever repay him’
Trump says he ‘disagrees 100%’ with U.S. Attorney Jeanine Pirro over Reflecting Pool case
Assisted living sent resident to doctor’s appointment after giving him 18 shots, 5 am beer: officials
Mamdani extends deadline for NYC homeowners to seek exemption from new pied-à-terre tax
DSA candidate pushes federal AI data center moratorium with Michigan early voting underway
Trump immigration agenda faces setback as Obama-appointed judge issues fresh TPS stay
Israeli president says Palestinian peace ‘requires’ acceptance of Israel in warning against Mamdani
New Christian Persecution Report Shows Most Dangerous Countries on Earth for Believing in Jesus
Why Gen Z Is Breaking This Longtime Workplace Taboo
Reporter’s Notebook: Why Fauci’s 111 Fifth Amendment pleas could end up before the courts
Trump blasts rogue GOP senators for blocking Blanche nomination, vows anti-weaponization bill fight
Trump Says AI Data Centers Pledge Will Make Power Bills ‘Actually Come Down’
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Democratic socialist headed for $142K legislature salary begs for rent handout, deletes post after backlash
Multiple people killed in shooting at Idaho In-N-Out restaurant, suspect dead
ICE arrests illegal immigrant accused of rape, multiple sex crimes after release from Maryland jail
Father of 10-year-old boy breaks silence after viral beach rescue: ‘No way I could ever repay him’
Trump says he ‘disagrees 100%’ with U.S. Attorney Jeanine Pirro over Reflecting Pool case
Assisted living sent resident to doctor’s appointment after giving him 18 shots, 5 am beer: officials
Mamdani extends deadline for NYC homeowners to seek exemption from new pied-à-terre tax
DSA candidate pushes federal AI data center moratorium with Michigan early voting underway
Trump immigration agenda faces setback as Obama-appointed judge issues fresh TPS stay
Israeli president says Palestinian peace ‘requires’ acceptance of Israel in warning against Mamdani
New Christian Persecution Report Shows Most Dangerous Countries on Earth for Believing in Jesus
Why Gen Z Is Breaking This Longtime Workplace Taboo
Reporter’s Notebook: Why Fauci’s 111 Fifth Amendment pleas could end up before the courts
Trump blasts rogue GOP senators for blocking Blanche nomination, vows anti-weaponization bill fight
Trump Says AI Data Centers Pledge Will Make Power Bills ‘Actually Come Down’
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
